Developer docs
API playgroundTry for free, no card

Search company profiles

MultiMedia Pharma Sciences

Full company profile

uuid000cn6g

Namestring
MultiMedia Pharma Sciences
Company typeenum
Private
Founded yearint
1996
Descriptiontext

MultiMedia Pharma Sciences is a privately held biopharmaceutical drug development and manufacturing company founded in 1996. Per firmographic records, the company is headquartered in Göttingen, Germany, with a separately noted office location in Cranbury, United States; this geographic split suggests potential transatlantic operations, though the firmographic data is internally inconsistent and should be verified. The company employs 501-1000 staff, consistent with a mid-sized contract development and manufacturing organization (CDMO) or specialty biopharma manufacturer. The website URL listed (biopharminternational.com) corresponds to a third-party industry trade publication rather than a proprietary corporate site, which further limits visibility into the company's product portfolio and service offering.

No specific products, service lines, therapeutic areas, manufacturing platforms, or proprietary technologies are disclosed in the input data. The input material is drawn from BioPharm International's general industry coverage and does not contain company-specific content; structured fields for products and services, partnerships, certifications, management team, and corporate history are all empty. As a result, the company's precise positioning within the biopharma value chain — whether as a CDMO, a specialty drug developer, or a hybrid — cannot be determined from the available evidence.

The most recent documented capital-markets event is a 2012 funding round referencing Ingleside Investors as an investor (4th round overall), with no disclosed amount. No subsequent funding rounds, M&A activity, partnerships, product launches, or leadership changes are present in the input. The company is described as for-profit and private, with no IPO activity, parent company, or subsidiary structure disclosed. Overall, the data supports only a baseline description; deeper analytical claims about business model, revenue mechanics, or go-to-market strategy would require additional primary-source verification.

Short descriptiontext

MultiMedia Pharma Sciences is a privately held biopharmaceutical drug development and manufacturing company founded in 1996, with 501-1000 employees and reported presence in Göttingen, Germany and Cranbury, United States.

Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersGöttingen, Germany
HQ citystring
Göttingen
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biopharmaceutical development, drug manufacturing, contract manufacturing, API manufacturing, pharmaceutical services
Industry1 code
PRIMARYEDAGAFAB
Medical, Clinical & Biomedical Scholarly Publishing
Education/Educational Publishing & Learning Content/Academic & Scholarly Publishing (Journals, Monographs)
NAICS code1 code
  • Broadcasting and Content Providers516
SIC code1 code
  • Periodicals: Publishing Or Publishing & Printing2721
Product category
Biopharmaceutical Manufacturing
Social media profiles1 record
Cost components5 values
Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

MultiMedia Pharma Sciences is a biopharmaceutical drug development and manufacturing company. It develops and produces pharmaceutical drug substances and finished products for the biopharmaceutical industry. The firm is headquartered in Göttingen, Germany, with operations in the United States.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Biopharmaceutical Drug Development and Manufacturing Services
CategoryBiopharmaceutical Contract Manufacturing
Description

Drug development and manufacturing services for biopharmaceutical and pharmaceutical clients, covering drug substance and finished product production.

Expansion highlight1 record

Each record includes

Type, Description

Peers10 records
1INTERPHEX (RX Global)
TypeOthers
Description

Major pharmaceutical manufacturing conference explicitly referenced on the BioPharm International site; comparable as a biopharma manufacturing events franchise and a likely commercial partner.

TypeBroad incumbent
Description

Data and intelligence provider (Pink Sheet, Scrip, BioMedTracker) covering biopharma R&D, regulatory and clinical trials — competes for the same biopharma decision-maker audience and ad/sponsorship budget.

TypeBroad incumbent
Description

Long-standing biopharma industry news, jobs and intelligence platform with significant overlap in biomanufacturing and drug development coverage for the same professional audience.

TypeDirect peer
Description

UK-based pharmaceutical industry publication covering drug development, manufacturing and regulatory affairs — directly comparable in editorial scope and B2B positioning to BioPharm International.

TypeDirect peer
Description

Niche trade publication focused on pharmaceutical outsourcing and CDMO services — a topic area heavily featured in BioPharm International's Outsourcing/Contract Manufacturing coverage.

TypeEmerging player
Description

Digital-native biopharma news outlet that has rapidly captured advertising share and readership from legacy trade publications covering drug development and biopharma business.

TypeDirect peer
Description

B2B trade title focused on drug discovery, development and biopharma R&D pipelines — directly competes for the same pharmaceutical professional audience and advertiser base.

8Fierce Pharma
TypeBroad incumbent
Description

Large biopharma business news brand from Questex, covering pharma business, manufacturing and regulation at greater breadth — competes with BioPharm International for biopharma executive readership and ad spend.

TypeBroad incumbent
Description

Trade title focused on pharmaceutical business strategy, regulation and manufacturing operations — overlaps with BioPharm International's BioBusiness and Regulatory/GMP coverage for pharma executive readers.

10Pharmaceutical Technology
TypeDirect peer
Description

Peer trade publication covering pharmaceutical development, manufacturing, formulation and regulatory topics — overlaps almost entirely with BioPharm International's coverage of drug substance, finished product and bioprocessing.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MultiMedia Pharma Sciences

Biopharmaceutical Manufacturingbiopharminternational.com

MultiMedia Pharma Sciences is a privately held biopharmaceutical drug development and manufacturing company founded in 1996, with 501-1000 employees and reported presence in Göttingen, Germany and Cranbury, United States.

What MultiMedia Pharma Sciences does

MultiMedia Pharma Sciences is a privately held biopharmaceutical drug development and manufacturing company founded in 1996. Per firmographic records, the company is headquartered in Göttingen, Germany, with a separately noted office location in Cranbury, United States; this geographic split suggests potential transatlantic operations, though the firmographic data is internally inconsistent and should be verified. The company employs 501-1000 staff, consistent with a mid-sized contract development and manufacturing organization (CDMO) or specialty biopharma manufacturer. The website URL listed (biopharminternational.com) corresponds to a third-party industry trade publication rather than a proprietary corporate site, which further limits visibility into the company's product portfolio and service offering.

No specific products, service lines, therapeutic areas, manufacturing platforms, or proprietary technologies are disclosed in the input data. The input material is drawn from BioPharm International's general industry coverage and does not contain company-specific content; structured fields for products and services, partnerships, certifications, management team, and corporate history are all empty. As a result, the company's precise positioning within the biopharma value chain — whether as a CDMO, a specialty drug developer, or a hybrid — cannot be determined from the available evidence.

The most recent documented capital-markets event is a 2012 funding round referencing Ingleside Investors as an investor (4th round overall), with no disclosed amount. No subsequent funding rounds, M&A activity, partnerships, product launches, or leadership changes are present in the input. The company is described as for-profit and private, with no IPO activity, parent company, or subsidiary structure disclosed. Overall, the data supports only a baseline description; deeper analytical claims about business model, revenue mechanics, or go-to-market strategy would require additional primary-source verification.

MultiMedia Pharma Sciences firmographics

Firmographics
Name
MultiMedia Pharma Sciences
Website
https://biopharminternational.com
Company type
Private
Founded year
1996
Headcount range
1–10 employees
Short description
MultiMedia Pharma Sciences is a privately held biopharmaceutical drug development and manufacturing company founded in 1996, with 501-1000 employees and reported presence in Göttingen, Germany and Cranbury, United States.
Ownership category
akta.pro rank

MultiMedia Pharma Sciences industry classification

Industry
Product category
Biopharmaceutical Manufacturing
NAICS
Broadcasting and Content Providers (516)
SIC
Periodicals: Publishing Or Publishing & Printing (2721)
akta.pro industry
PRIMARYEDAGAFAB
Medical, Clinical & Biomedical Scholarly Publishing
Education/Educational Publishing & Learning Content/Academic & Scholarly Publishing (Journals, Monographs)

Keywords

  • Biopharmaceutical development
  • Drug manufacturing
  • Contract manufacturing
  • API manufacturing
  • Pharmaceutical services

Where MultiMedia Pharma Sciences is headquartered

Location

Headquarters

HQ city
Göttingen
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

MultiMedia Pharma Sciences business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure

MultiMedia Pharma Sciences product offering

Product offering

Core offering

MultiMedia Pharma Sciences is a biopharmaceutical drug development and manufacturing company. It develops and produces pharmaceutical drug substances and finished products for the biopharmaceutical industry. The firm is headquartered in Göttingen, Germany, with operations in the United States.

Differentiator

Problem solved

Functional benefit

Products and services

  • Biopharmaceutical Drug Development and Manufacturing Services Drug development and manufacturing services for biopharmaceutical and pharmaceutical clients, covering drug substance and finished product production.

Companies that use MultiMedia Pharma Sciences

Customer profile

Ideal customer profiles1 record

MultiMedia Pharma Sciences technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

MultiMedia Pharma Sciences partnerships and signals

Strategic signal

Expansion highlights1 record

MultiMedia Pharma Sciences competitors and assessment

Company assessment

Others

  • INTERPHEX (RX Global): Major pharmaceutical manufacturing conference explicitly referenced on the BioPharm International site; comparable as a biopharma manufacturing events franchise and a likely commercial partner.

Broad incumbents

  • Citeline (formerly Pharma intelligence): Data and intelligence provider (Pink Sheet, Scrip, BioMedTracker) covering biopharma R&D, regulatory and clinical trials — competes for the same biopharma decision-maker audience and ad/sponsorship budget.
  • BioSpace: Long-standing biopharma industry news, jobs and intelligence platform with significant overlap in biomanufacturing and drug development coverage for the same professional audience.
  • Fierce Pharma: Large biopharma business news brand from Questex, covering pharma business, manufacturing and regulation at greater breadth — competes with BioPharm International for biopharma executive readership and ad spend.
  • Pharmaceutical Executive: Trade title focused on pharmaceutical business strategy, regulation and manufacturing operations — overlaps with BioPharm International's BioBusiness and Regulatory/GMP coverage for pharma executive readers.

Direct peers

  • PharmaTimes: UK-based pharmaceutical industry publication covering drug development, manufacturing and regulatory affairs — directly comparable in editorial scope and B2B positioning to BioPharm International.
  • Outsourced Pharma: Niche trade publication focused on pharmaceutical outsourcing and CDMO services — a topic area heavily featured in BioPharm International's Outsourcing/Contract Manufacturing coverage.
  • Drug Discovery & Development: B2B trade title focused on drug discovery, development and biopharma R&D pipelines — directly competes for the same pharmaceutical professional audience and advertiser base.
  • Pharmaceutical Technology: Peer trade publication covering pharmaceutical development, manufacturing, formulation and regulatory topics — overlaps almost entirely with BioPharm International's coverage of drug substance, finished product and bioprocessing.

Emerging players

  • Endpoints News: Digital-native biopharma news outlet that has rapidly captured advertising share and readership from legacy trade publications covering drug development and biopharma business.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights6 records

Customer concentration

MultiMedia Pharma Sciences social profiles

Digital presence

MultiMedia Pharma Sciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MultiMedia Pharma Sciences leadership team

Management profile

Number of profiles

MultiMedia Pharma Sciences funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MultiMedia Pharma Sciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MultiMedia Pharma Sciences

What does MultiMedia Pharma Sciences do?

MultiMedia Pharma Sciences is a biopharmaceutical drug development and manufacturing company. It develops and produces pharmaceutical drug substances and finished products for the biopharmaceutical industry. The firm is headquartered in Göttingen, Germany, with operations in the United States.

When was MultiMedia Pharma Sciences founded?

MultiMedia Pharma Sciences was founded in 1996. It employs 1 to 10 people.

Where is MultiMedia Pharma Sciences based?

MultiMedia Pharma Sciences is headquartered in Göttingen, Germany, in the Europe region.

Who are MultiMedia Pharma Sciences's main competitors?

INTERPHEX (RX Global) is listed as an others. Broad incumbents are Citeline (formerly Pharma intelligence), BioSpace, Fierce Pharma and Pharmaceutical Executive. Direct peers are PharmaTimes, Outsourced Pharma, Drug Discovery & Development and Pharmaceutical Technology. Endpoints News is listed as an emerging player.

Does MultiMedia Pharma Sciences have an API?

No public API is recorded for MultiMedia Pharma Sciences.

What industry is MultiMedia Pharma Sciences in?

MultiMedia Pharma Sciences's product category is Biopharmaceutical Manufacturing. Its primary akta.pro industry code is EDAGAFAB, Medical, Clinical & Biomedical Scholarly Publishing. Its NAICS code is 516 and its SIC code is 2721.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals